Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
T Cell Types and Functions
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Tuberculosis I
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Response
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 4, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Tomas Urbina1, Paul Gabarre2,3, Vincent Bonny2,3
1Intensive Care Unit, Saint-Antoine Hospital, Public Assistance-Hospitals of Paris, Paris, France - tomas.urbina@aphp.fr.
Corticosteroid treatment in critically ill COVID-19 patients reduced C-reactive protein and fibrinogen but increased TNF-α. Biomarker kinetics may guide personalized immunomodulatory therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: